title: Generation of free radicals by emodic acid and its [D-Lys6]GnRH-conjugate.
abstract: In an attempt to develop an efficient chemotherapeutic agent targeted at malignant cells that express receptors to gonadotropin releasing hormone (GnRH) we coupled [D-Lys6]GnRH covalently to an emodin derivative, i.e. emodic acid (Emo) to yield [D-Lys6(Emo)]GnRH. Emodin is a naturally occurring anthraquinone which is widely used as a laxative and has other versatile biological activities. Physico-chemical studies employing electron paramagnetic resonance and electrochemistry of the conjugate as well as the (Emo) moiety showed that these compounds could be easily reduced either chemically, photochemically or enzymatically to their corresponding semiquinones. In the presence of oxygen the semiquinones generated reactive oxygen species (ROS), mainly superoxide and hydroxyl radicals, which were detected by the spin trapping method. Moreover, upon irradiation with visible light these compounds produced ROS and a highly reactive excited triplet state of Emo, which by itself may cause the oxidation of certain electron acceptors such as amino acids and bases of nucleic acids. Thus, [D-Lys6]GnRH-photosensitizer conjugates may be potentially used for targeted photodynamic chemotherapy aimed at treating cancer cells that carry GnRH receptors. These conjugates may also induce cytotoxicity in the dark similar to common conventional chemotherapeutic agents. The peptidic moiety, [D-Lys6]GnRH, was found to be stable toward highly reactive ROS generated either from enzymatic reduction or upon photoirradiation. The physico-chemical properties of Emo were only marginally influenced by the peptidic [D-Lys6]GnRH carrier.
authors.affiliation: Departments of Organic Chemistry and Neurobiology, Weizmann Institute of Science, Rehovot, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Rahimipour
authors.forename: I
authors.initials: I
authors.lastname: Bilkis
authors.forename: V
authors.initials: V
authors.lastname: Péron
authors.forename: G
authors.initials: G
authors.lastname: Gescheidt
authors.forename: F
authors.initials: F
authors.lastname: Barbosa
authors.forename: Y
authors.initials: Y
authors.lastname: Mazur
authors.forename: Y
authors.initials: Y
authors.lastname: Koch
authors.forename: L
authors.initials: L
authors.lastname: Weiner
authors.forename: M
authors.initials: M
authors.lastname: Fridkin
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology; D004642:Emodin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D005609:Free Radicals / Q000737:chemistry; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D010777:Photochemistry; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000737:chemistry / Q000494:pharmacology; D011966:Receptors, LHRH / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D005609:Free Radicals; D017319:Photosensitizing Agents; D011966:Receptors, LHRH; D007987:Gonadotropin-Releasing Hormone; C035029:LHRH, Lys(6)-; D004642:Emodin